EV/EBITDA:
29.92-0.43(-1.42%)Summary
- As of today, APLS EV/EBITDA is 29.92, with a fall of -0.43 (-1.42%) during the most recent trading session on November 19, 2025.
- Over the past year, APLS EV/EBITDA has increased by +46.53 (+280.13%).
- APLS EV/EBITDA is now -35.32% below its all-time high of 46.26.
Performance
APLS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APLS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -1.4% | -1.4% | -1.4% |
| 1M1 Month | - | - | -20.7% |
| 3M3 Months | +262.4% | -29.2% | -27.1% |
| 6M6 Months | +336.7% | +5.4% | +10.1% |
| YTDYTD | +221.1% | -39.1% | -39.0% |
| 1Y1 Year | +280.1% | -33.2% | -32.9% |
| 5Y5 Years | +581.8% | -11.9% | -53.1% |
APLS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 46.26 | -35.3% | 29.22 | +2.4% |
| 3M | 3-Month | 46.26 | -35.3% | -19.74 | +251.6% |
| 6M | 6-Month | 46.26 | -35.3% | -19.74 | +251.6% |
| 1Y | 1-Year | 46.26 | -35.3% | -26.77 | +211.8% |
| 3Y | 3-Year | 46.26 | -35.3% | -26.77 | +211.8% |
| 5Y | 5-Year | 46.26 | -35.3% | -26.77 | +211.8% |
| All-Time | All-Time | 46.26 | -35.3% | -30.85 | +197.0% |
APLS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 29.92(+221.1%) |
| 2024 | -24.70(-84.1%) |
| 2023 | -13.42(-50.6%) |
| 2022 | -8.91(-15.7%) |
| Date | Value |
|---|---|
| 2021 | -7.70(+57.5%) |
| 2020 | -18.10(-195.3%) |
| 2019 | -6.13(+2.5%) |
| 2018 | -6.29 |
FAQ
- What is Apellis Pharmaceuticals, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Apellis Pharmaceuticals, Inc.?
- What is APLS EV/EBITDA year-to-date change?
- What is Apellis Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Apellis Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of APLS is 29.92
What is the all-time high EV/EBITDA for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high EV/EBITDA is 46.26
What is APLS EV/EBITDA year-to-date change?
Apellis Pharmaceuticals, Inc. EV/EBITDA has changed by +54.62 (+221.13%) since the beginning of the year
What is Apellis Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, APLS EV/EBITDA has changed by +46.53 (+280.13%)